Wilmington, DE, United States of America

Gerald Siefring, Jr


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Gerald Siefring, Jr.

Introduction

Gerald Siefring, Jr. is an accomplished inventor based in Wilmington, DE (US). He has made significant contributions to the field of immunology through his innovative patent. His work focuses on enhancing the bioavailability of hydrophobic drugs, which is crucial for effective medical treatments.

Latest Patents

Gerald Siefring, Jr. holds a patent titled "Methods for detection of immunosuppressant drugs." This patent discloses methods and reagents designed to enhance the bioavailability of hydrophobic drugs. The invention involves forming a combination in a medium that includes a sample suspected of containing a hydrophobic drug, a hemolytic agent, and a bioavailability agent. The bioavailability agent can be an ionic or non-ionic detergent, which is essential for improving the drug's effectiveness. The process includes incubating the medium under specific conditions to facilitate the determination of the hydrophobic drug's presence and amount.

Career Highlights

Gerald Siefring, Jr. is currently employed at Siemens Healthcare Diagnostics GmbH, where he continues to contribute to advancements in healthcare diagnostics. His expertise in drug detection and bioavailability has positioned him as a valuable asset in the field.

Collaborations

Throughout his career, Gerald has collaborated with notable colleagues, including Tie Q Wei and Christy Schaible. These collaborations have further enriched his research and development efforts.

Conclusion

Gerald Siefring, Jr. exemplifies innovation in the field of immunology with his patent on methods for detecting immunosuppressant drugs. His work not only enhances drug bioavailability but also contributes to the broader medical community's understanding of drug interactions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…